1Goldberg RB. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications[J]. J Clin Endocrinol Metab, 2009, 94(9): 3171-3182.
5Kang ES, Kim HJ, Ahn CW, et al. Relationship of serm high sensitivity C-reactive protein to metabolic syndrome and mcrovascular complications in type 2 diabetes[J]. Acta Disbetol, 2001, 38(4): 153-155.
6Otto C, Engelschalk C, Fraunberger R et al. Lack of an accosiation of urinary albumin excretion with interleukin-6 or C reactive protein in patients with type 2 diabetes[J]. Acta Dialbetnl, 2001, 38(4): 153-155.
9Agius E, Attard G, Shakespeare L, et al. Familial factors in diabetic nephropathy: an offspring study[J]. Diabet Med, 2006, 23(3): 331-334.
10DeFilippi C, Wassenman S, Rosanio S, et al. Cardiac troponin T and C-reactive protein for predicting prognosis, coronary atherosclersis, and cardiomyopathy in patients undergoing long-term hemodialysis[J]. JAMA, 2003, 290(3): 353-359.
7Walder K, Kantham L, Mcmillan JS, et al. Tanis: a link between type 2 diabetes an inflammation? [J]. Diabetes, 2002,51 (6) : 1859-1866.
8Kunsch C, Medford RM. Oxidative stress as a regulator of gene expression in the vasculature [ J]. Circ Res, 1999, 85 (8) :753-766.
9Verma S, Li SH, Badiwala MV, et al. Endothelin antagoniam and interleukin-6 inhibition attenuate the proatherogenic effects of C-reactive protein [ J]. Circulation, 2002, 105 ( 16 ) : 1890-1896.
10Turner R,Cull C,Holmen IL.United Kingdom Prospective Diabetes Study 17:a 9-year update of a randomized controlled trial on the effect of improved metabolic control on complications in non-insulin-dependent diabetes mellitus[J].Ann Intern Med,1996,124(1):136-145.
4Atkins RC. The changing patterns of chronic kindey disease :the need to develop strateigies for prevention relevant to different regions and coun- tries. Kindey Int,2005,68 : 83-85.
5Erbagic AB ,Tarokcioglu M ,Coskun Y, et al. Mediators of inflammation in childem with type 1 daibetes mellitus:cytokines in type 1 diabetes children. Clin Biochcm,2001,34 :645-650.
6Irving RJ,Noon JP,Watt GC,et al. Activation of the endothelin system in insulin resistance. QJM ,2001,94:321-326.
7Oberg BP, McMenamin E, Lucas FL,et al. Increased prevelence of oxi- dant stress and inflammation in patient with moderate to severe chronic kindey disease. Kindey Int,2004,65:1009-1016.
8Meigs JB, Mittleman MA, Nathan DM, et al. Hyperinsulinemia, hyper- glycemia and impaired hemostasis : the Framingham Offspring Study. JA- MA ,2000,283:221-228.
9Pradhan AD,Manson JE,Rifai N,et al.C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. Journal of the American Medical Association, The . 2001
10Dandona P,Aljada A,Dhindsa S.Insulin as an anti-inflammatory andantiatherosclerotic. Hormones . 2003
